INSM Latest Headlines

RBC Capital Reaffirms Their Buy Rating on Insmed (INSM)

at www.tipranks.com (Wed, 26-Aug 9:45 PM)

Insmed: Japan Brinsupri Launch Underscores Long-Term Growth, Supports Unchanged $218 Price Target and Overweight Rating

at www.tipranks.com (Tue, 25-Aug 7:26 AM)

Insmed Earns Buy Rating as Brinsupri Japan Approval Drives Stronger Global Outlook and Price Target Raised to $195

at www.tipranks.com (Mon, 24-Aug 3:55 PM)

Insmed Lifts Revenue Targets, Reports Breakout Second Quarter on Brensocatib and Pipeline Progress

Market Chameleon (Thu, 6-Aug 11:14 AM)

Insmed Lifts Revenue Outlook as BRINSUPRI Surges 49% in Q2 and Pipeline Expands

Market Chameleon (Thu, 6-Aug 7:45 AM)

Insmed Delivers Positive 12-Month Data: TPIP Shows Sustained Benefits for Pulmonary Arterial Hypertension Patients

Market Chameleon (Thu, 16-Jul 8:33 AM)